Clustering of admission hyperglycemia, impaired renal function and anemia and its impact on in-hospital outcomes in patients with ST-elevation myocardial infarction

Atherosclerosis

Volumn 209, Issue 2, 2010, Pages 558-564

  Kruk, Mariusz ^a   Przyełuski, Jakub ^a   Kalińczuk, Łukasz ^a   Pregowski, Jerzy ^a   Kaczmarska, Edyta ^a   Petryka, Joanna ^a   Kłopotowski, Mariusz ^a   Kepka, Cezary ^a   Chmielak, Zbigniew ^a   Demkow, Marcin ^a   Ciszewski, Andrzej ^a   Piotrowski, Walerian ^a   Karcz, Maciej ^a   Bekta, Paweł ^a   Witkowski, Adam ^a   Ruzyłło, Witold ^a  

^a INSTITUTE OF CARDIOLOGY   (Poland)

Author keywords

Anemia; Diabetes; Myocardial infarction; Primary angioplasty; Renal disease

Indexed keywords

CREATININE; GLUCOSE;

ADULT; AGED; ANEMIA; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CREATININE BLOOD LEVEL; FEMALE; HEART INFARCTION; HEMATOCRIT; HOSPITAL ADMISSION; HUMAN; HYPERGLYCEMIA; INCIDENCE; KIDNEY DYSFUNCTION; MAJOR CLINICAL STUDY; MALE; MORTALITY; PERCUTANEOUS CORONARY INTERVENTION; PREVALENCE; PRIORITY JOURNAL; PROSPECTIVE STUDY; RISK FACTOR; ST SEGMENT ELEVATION; TRANSLUMINAL CORONARY ANGIOPLASTY; TREATMENT RESPONSE;

EID: 77950047707     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2009.09.074     Document Type: Article

References (32)

1. Van de Werf F., Bax J., Betriu A., et al. Management of acute myocardial infarction in patients presenting with persistent ST-segment elevation: the Task Force on the Management of ST-Segment Elevation Acute Myocardial Infarction of the European Society of Cardiology. Eur Heart J 2008, 29:2909-2945.
2. Task Force for Diagnosis and Treatment of Non-ST-Segment Elevation Acute Coronary Syndromes of European Society of Cardiology Guidelines for the diagnosis and treatment of non-ST-segment elevation acute coronary syndromes. Eur Heart J 2007, 28:1598-1660.
3. Fourth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice European guidelines on cardiovascular disease prevention in clinical practice: executive summary. Eur Heart J 2007, 28:2375-2414.
4. Anderson J.L., Adams C.D., Antman E.M., et al. ACC/AHA 2007 guidelines for the management of patients with unstable angina/non-ST-elevation myocardial infarction: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (writing committee to revise the 2002 guidelines for the management of patients with unstable angina/non-ST-elevation myocardial infarction) developed in collaboration with the American College of Emergency Physicians, the Society for Cardiovascular Angiography and Interventions, and the Society of Thoracic Surgeons endorsed by the American Association of Cardiovascular and Pulmonary Rehabilitation and the Society for Academic Emergency Medicine. J Am Coll Cardiol 2007, 50:1-157.
5. Franklin K., Goldberg R.J., Spencer F., et al. Implications of diabetes in patients with acute coronary syndromes. The global registry of acute coronary events. Arch Intern Med 2004, 164:1457-1463.
6. Dotevall A., Hasdai D., Wallentin L., Battler A., Rosengren A. Diabetes mellitus: clinical presentation and outcome in men and women with acute coronary syndromes. Data from the Euro Heart Survey ACS. Diabet Med 2005, 22:1542-1550.
7. Prasad A., Stone G.W., Stuckey T.D., et al. Impact of diabetes mellitus on myocardial perfusion after primary angioplasty in patients with acute myocardial infarction. J Am Coll Cardiol 2005, 45:508-514.
8. Nikolsky E., Aymong E.D., Halkin A., et al. Impact of anemia in patients with acute myocardial infarction undergoing primary percutaneous coronary intervention: analysis from the controlled abciximab and device investigation to lower late angioplasty complications (CADILLAC) trial. J Am Coll Cardiol 2004, 44:547-553.
9. Al Falluji N., Lawrence-Nelson J., Kostis J.B., Lacy C.R., Ranjan R., Wilson A.C. Effect of anemia on 1-year mortality in patients with acute myocardial infarction. Am Heart J 2002, 144:636-641. Myocardial Infarction Data Acquisition System (MIDAS #8) Study Group.
10. Nesto R.W., Lago R.M. Glucose: a biomarker in acute myocardial infarction ready for prime time?. Circulation 2008, 117:990-992.
11. WHO Scientific Group Nutritional Anemias. Report of a WHO Scientific GroupGeneva. World Health Organization; 1968.
12. Mancia G., De Backer G., Dominiczak A., et al. ESH-ESC Task Force on the Management of Arterial Hypertension. 2007 ESH-ESC practice guidelines for the management of arterial hypertension. J Hypertens 2007, 25(9):1751-1762.
13. Rao S.V., O'Grady K., Pieper K.S., et al. A comparison of the clinical impact of bleeding measured by two different classifications among patients with acute coronary syndromes. J Am Coll Cardiol 2006, 47:809-816.
14. Sprecher D.L., Pearce G.L. How deadly is the " deadly quartet" ? A post-CABG evaluation. J Am Coll Cardiol 2000, 36:1159-1165.
15. Everitt B.S. Dictionary of Statistics in the Medical Sciences 1995, Cambridge University Press, Cambridge, p. 252.
16. [accessed 24-04-2009]. http://dictionary.cambridge.org/define.asp%3Fkey=80840%26dict=CALD.
17. El-Achkar T.M., Ohmit S.E., McCullough P.A., et al. Higher prevalence of anemia with diabetes mellitus in moderate kidney insufficiency: the Kidney Early Evaluation Program. Kidney Int 2005, 67:1483-1488.
18. McFarlane S.I., Chen S.C., Whaley-Connell A.T., et al. Prevalence and associations of anemia of CKD: Kidney Early Evaluation Program (KEEP) and National Health and Nutrition Examination Survey (NHANES) 1999-2004. Am J Kidney Dis 2008, 51(4 (Suppl. 2)):S46-S55.
19. Hsu C.Y., McCulloch C.E., Curhan G.C. Epidemiology of anemia associated with chronic renal insufficiency among adults in the United States: results from the Third National Health and Nutrition Examination Survey. J Am Soc Nephrol 2002, 13:504-510.
20. Agodoa L., Eggers P. USRDS 2006 Annual Data Report 2006, NIDDK, NIH, DHHS, Bethesda, MD.
21. Astor B.C., Muntner P., Levin A., et al. Association of kidney function with anemia: the Third National Health and Nutrition Examination Survey (1988-1994). Arch Intern Med 2002, 162:1401-1408.
22. Bosman D.R., Winkler A.S., Marsden J.T., et al. Anemia with erythropoietin deficiency occurs early in diabetic nephropathy. Diabetes Care 2001, 24:495-499.
23. Stone G.W., Grines C.L., Cox D.A., et al. Comparison of angioplasty with stenting, with or without abciximab, in acute myocardial infarction. N Engl J Med 2002, 346:957-966.
24. Coca S.G., Krumholz H.M., Garg A.X., Parikh C.R. Underrepresentation of renal disease in randomized controlled trials of cardiovascular disease. JAMA 2006, 296:1377-1384.
25. Hordijk-Trion M., Lenzen M., Wijns W., et al. Patients enrolled in coronary intervention trials are not representative of patients in clinical practice: results from the Euro Heart Survey on Coronary Revascularization. Eur Heart J 2006, 27:671-678.
26. Capes S.E., Hunt D., Malmberg K., Gerstein H.C. Stress hyperglycaemia and increased risk of death after myocardial infarction in patients with and without diabetes: a systematic overview. Lancet 2000, 9206:773-778.
27. Gibson C.M., Pinto D.S., Murphy S.A., et al. Association of creatinine and creatinine clearance on presentation in acute myocardial infarction with subsequent mortality. J Am Coll Cardiol 2003, 42:1535-1543.
28. Eagle K.A., Lim M.J., Dabbous O.H., et al. A validated prediction model for all forms of acute coronary syndrome. Estimating the risk of 6-month postdischarge death in an international registry. JAMA 2004, 291:2727-2733.
29. Assali A.R., Brosh D., Ben-Dor I., et al. The impact of renal insufficiency on patients' outcomes in emergent angioplasty for acute myocardial infarction. Catheter Cardiovasc Interv 2007, 69:395-400.
30. Kruk M., Przyłuski J., Kalińczuk L., et al. Hemoglobin, leukocytosis and clinical outcomes of ST-elevation myocardial infarction treated with primary angioplasty: ANIN Myocardial Infarction Registry. Circ J 2009, 73:323-329.
31. Fitchett D. The impact of bleeding in patients with acute coronary syndromes: how to optimize the benefits of treatment and minimize the risk. Can J Cardiol 2007, 23:663-671.
32. Marenzi G., Assanelli E., Campodonico J., et al. Contrast volume during primary percutaneous coronary intervention and subsequent contrast-induced nephropathy and mortality. Ann Intern Med 2009, 150:170-177.